Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination therapy consists of the local anesthetic **lidocaine** and the lubricant **liquid paraffin**. Lidocaine is a sodium channel blocker that provides topical anesthesia to the urethral mucosa, while liquid paraffin serves as a mechanical lubricant to facilitate the insertion of medical instruments. This specific regimen is being investigated by the **Second Xiangya Hospital of Central South University** to evaluate its efficacy in providing pain relief and reducing procedural trauma for male patients undergoing rigid cystoscopy, a common procedure for the diagnosis and surveillance of **bladder cancer**.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + liquid paraffin.